Lv2
110 积分 2023-07-24 加入
A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21)
3天前
求助中
Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma
1个月前
已完结
Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance
1个月前
已完结
Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma
2个月前
已关闭
The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions
3个月前
已完结
CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma
4个月前
已完结
Oleuropein regulates ubiquitination-mediated Mcl-1 turnover and exhibits antitumor activity
6个月前
已完结
PAICS ubiquitination recruits UBAP2 to trigger phase separation for purinosome assembly
7个月前
已完结
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein–Targeted Cyclic Peptide–Based Radiotheranostic for Imaging and Therapy
3个月前
已采纳
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein–Targeted Cyclic Peptide–Based Radiotheranostic for Imaging and Therapy
3个月前
已采纳
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein–Targeted Cyclic Peptide–Based Radiotheranostic for Imaging and Therapy
3个月前
已采纳
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein–Targeted Cyclic Peptide–Based Radiotheranostic for Imaging and Therapy
3个月前
已采纳
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein–Targeted Cyclic Peptide–Based Radiotheranostic for Imaging and Therapy
3个月前
已采纳
皖公网安备34019202002308
